Eterobarb

From Self-sufficiency
Jump to: navigation, search
Eterobarb
File:Eterobarb.png
Systematic (IUPAC) name
5-ethyl-1,3-bis(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione
Clinical data
Routes of
administration
Oral
Identifiers
CAS Number 27511-99-5
ATC code none
PubChem CID 33925
Chemical data
Formula C16H20N2O5
Molar mass 320.340 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Eterobarb (Antilon) is a barbiturate derivative. It has mainly anticonvulsant action with less sedative effects than the closely related compound phenobarbital. It saw reasonable success in clinical trials, but is not in widespread medical use.[1][2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Gallagher BB, Baumel IP, Woodbury SG, Dimicco JA. Clinical evaluation of eterobarb, a new anticonvulsant drug. Neurology. 1975 May;25(5):399-404. PMID 1094318
  2. Smith DB, Goldstein SG, Roomet A. A comparison of the toxicity effects of the anticonvulsant eterobarb (antilon, DMMP) and phenobarbital in normal human volunteers. Epilepsia. 1986 Mar-Apr;27(2):149-55. PMID 3956454